A quick, honest look at seven telehealth GLP-1 programs. Each review covers who it’s best for, what it costs, and the catch worth knowing before you sign up.


Before you read: Brand-name GLP-1s (Wegovy, Zepbound) run roughly $900–$1,350/month without insurance. Compounded versions of the same drugs (semaglutide, tirzepatide) typically run $200–$600/month and are not FDA-approved as finished medications — they’re a different thing from the brand drugs. There’s also now an FDA-approved GLP-1 pill (Foundayo) starting around $149/month, and Medicare begins limited GLP-1 coverage on July 1, 2026. The FDA has been actively warning telehealth companies over how they market compounded drugs, so the fine print matters more than it used to.


This is general information, not medical advice. Talk to a licensed clinician before starting any medication, and confirm current pricing directly with each provider.



Category 1: Weight-loss-first specialists


Built around GLP-1 weight loss from the start.


TrimRx


Best for: Anyone who wants the lowest honest price with no surprises.


One of the more transparent compounded-GLP-1 shops. It offers compounded semaglutide and tirzepatide with clear, upfront pricing and no membership fee layered on top. As of mid-2026 it had not appeared on the FDA’s published list of warning letters, which is a point in its favor in a crowded, scrutinized market.



  • The good: Transparent pricing, no membership fee, focused purely on weight loss.

  • The catch: Compounded only — that means no FDA-approved finished product, so quality oversight rests on the compounding pharmacy.

  • Bottom line: A solid budget-first pick if you’re comfortable with compounded medication.


ShedRx


Best for: People who want some accountability on whether it actually works.


A weight-loss specialist with one feature that stands out: a written “lose at least 10% of your body weight or get a full refund” promise, with the terms in the contract rather than the marketing. It reports a large and active member base and meaningful average weight loss across members.



  • The good: Concrete, contract-backed refund promise; established track record.

  • The catch: Confirm the exact program name and current terms — refund conditions usually have requirements (staying on plan, hitting check-ins).

  • Bottom line: Worth a look if a money-back guarantee gives you confidence to start.



Note: you listed this as “TryShed” — I matched it to ShedRx. Confirm that’s the brand you mean.



MEDVi


Best for: Bargain hunters who will read the fine print carefully.


A fast-growing, AI-driven platform offering very low-cost compounded GLP-1s. It scaled enormously and made big headlines in early 2026. It also received an FDA warning letter in February 2026 over website language that implied its compounded drugs were FDA-approved and that the company itself was the compounder.



  • The good: Among the cheapest options; slick, fast sign-up.

  • The catch: The FDA warning letter (and reported litigation) is a real trust flag. A warning letter isn’t a finding of guilt, but it tells you the marketing crossed a line the agency cared about.

  • Bottom line: Low price, higher risk. Go in with eyes open and verify current claims yourself.



Category 2: Multi-condition platforms with GLP-1 added on


Started in another health area (men’s optimization, sexual health, skincare) and expanded into weight loss.


Maximus Tribe


Best for: Men already doing (or interested in) hormone and performance optimization.


A men’s health platform built around testosterone, hair, blood flow and similar protocols, with a doctor-guided GLP-1 weight-loss protocol offered alongside. A clinician reviews your history and prescribes semaglutide or tirzepatide if appropriate; if you’re not approved, you’re refunded minus the consult fee.



  • The good: Fits naturally if you want weight loss as part of a broader optimization plan; real clinical review.

  • The catch: Weight loss is one line among many — not its core specialty.

  • Bottom line: A good fit for the optimization crowd; less obvious if weight loss is your only goal.


Peter MD


Best for: Men who want a no-frills, competitively priced compounded program.


Began as a testosterone-replacement clinic and added compounded GLP-1s as demand grew. Care is mostly asynchronous with messaging access to clinicians. Third-party reviews report semaglutide around $165/month and tirzepatide around $315/month, with the price holding steady across doses and the option to cancel anytime.



  • The good: Competitive flat pricing, fast intake, responsive provider messaging.

  • The catch: Not available in several states (including CA and TX); compounded only, and some users report batch-to-batch inconsistency.

  • Bottom line: Well-run and well-priced for a standard GLP-1 goal — check it serves your state first.



Strut Health


Best for: Anyone whose dealbreaker is needles.


A multi-condition telehealth platform (it began in sexual health and skincare) whose standout weight-loss feature is a needle-free option: compounded semaglutide as a dissolvable oral lozenge, alongside a standard injectable. It runs its own in-house compounding pharmacy rather than outsourcing, which generally means tighter quality control and faster turnaround. The consult is free and async, with unlimited follow-ups and dose adjustments at no extra cost.



  • The good: Rare needle-free oral lozenge; in-house pharmacy; free consult and unlimited follow-ups.

  • The catch: No tirzepatide and no brand-name drugs; doesn’t accept insurance, HSA or FSA, so the premium price (roughly $249–$349/month for the lozenge, ~$289/month injectable) has no tax-advantaged offset. Oral compounded formulas may absorb differently than injections.

  • Bottom line: The top pick if needles are what’s stopping you — less ideal if you want tirzepatide or the lowest price.


Rugiet Health


Best for: People who want options (including non-GLP-1) from a familiar brand.


Started as a men’s sexual-health brand known for dissolvable troches, and has expanded into medical weight loss. It offers GLP-1 medications (semaglutide and tirzepatide) plus oral, non-GLP-1 alternatives like bupropion, naltrexone and metformin — useful if a GLP-1 isn’t right for you.



  • The good: A genuine range of options, including alternatives to GLP-1s; convenient if you already use Rugiet.

  • The catch: Weight loss is newer and secondary to its core business, and program/pricing details are less clearly published — confirm current costs and what’s included before committing.

  • Bottom line: A reasonable choice if you value medication variety and already trust the brand; get the specifics in writing first.